Oral Protocatechuic Acid (PCA) as a Prophylaxis Against C. Acnes Wound Colonization During Total Shoulder Arthroplasty.

Overview

About this study

The purpose of this study is to determine whether a preoperative oral course of the nutritional supplement PCA can result in the decrease in C. acnes positive cultures and bacterial load seen at the time of elective primary Total Shoulder Arthroplasty (TSA).

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

Primary Shoulder Arthroplasty.

Exclusion Criteria:

Revision shoulder arthroplasty; open fracture; immunocompromised state.
Adults between the ages of 40-80 undergoing primary elective Total Shoulder Arthroplasty.

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 4/18/2024. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location	Status	Contact
Scottsdale/Phoenix, Ariz. Mayo Clinic principal investigator John Tokish, M.D.	Open for enrollment	Contact information: John Tokish M.D. (480) 342-2377 Tokish.John@mayo.edu

Mayo Clinic Location

Status

Contact

Scottsdale/Phoenix, Ariz.

Mayo Clinic principal investigator

John Tokish, M.D.

Open for enrollment

Contact information:

John Tokish M.D.

(480) 342-2377

Tokish.John@mayo.edu

More information

Publications

Publications are currently not available

Clinical Trials